Literature DB >> 17170067

The contribution of bone marrow-derived cells to the development of renal interstitial fibrosis.

Jinhua Li1, James A Deane, Naomi V Campanale, John F Bertram, Sharon D Ricardo.   

Abstract

Recent evidence suggests that bone marrow (BM)-derived cells may integrate into the kidney, giving rise to functional renal cell types, including endothelial and epithelial cells and myofibroblasts. BM-derived cells can contribute to repair of the renal peritubular capillary (PTC) network following acute ischemic injury. However, the cell fate and regulation of BM-derived cells during the progression of chronic renal disease remains unclear. Using chimeric mice transplanted with enhanced green fluorescent protein (EGFP)-expressing BM, we demonstrate that the number of BM-derived myofibroblasts coincided with the development of fibrosis in a mouse adriamycin (ADR)-induced nephrosis model of chronic, progressive renal fibrosis. Four weeks after ADR injection, increased numbers of BM-derived myofibroblasts were observed in the interstitium of ADR-injected mice. Six weeks after ADR injection, more than 30% of renal alpha-smooth muscle actin (+) (alpha-SMA+) interstitial myofibroblasts were derived from the BM. In addition, BM-derived cells were observed to express the endothelial cell marker CD31 and the myofibroblast marker alpha-SMA. Blockade of p38 mitogen-activated protein kinase (MAPK) and transforming growth factor (TGF)-beta1/Smad2 signaling was found to protect BM-derived PTC endothelial cells and inhibit the number of BM-derived von Willebrand factor (vWF)(+)/EGFP(+)/alpha-SMA(+) cells, EGFP(+)/alpha-SMA(+) cells, and total alpha-SMA(+) cells in ADR-injected mice. Inhibition of the p38 MAPK and TGF-beta1/Smad signaling pathways enhanced PTC repair by decreasing endothelial-myofibroblast transformation, leading to structural and functional renal recovery and the attenuation of renal interstitial fibrosis. Investigation of the signaling pathways that regulate the differentiation and survival of BM-derived cells in a progressive disease setting is vital for the successful development of cell-based therapies for renal repair.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17170067     DOI: 10.1634/stemcells.2006-0133

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  46 in total

Review 1.  Anti-fibrosis therapy and diabetic nephropathy.

Authors:  Anil Karihaloo
Journal:  Curr Diab Rep       Date:  2012-08       Impact factor: 4.810

2.  Transforming growth factor beta1 enhances tumor promotion in mouse skin carcinogenesis.

Authors:  Rolando Pérez-Lorenzo; Lauren Mordasky Markell; Kelly A Hogan; Stuart H Yuspa; Adam B Glick
Journal:  Carcinogenesis       Date:  2010-02-19       Impact factor: 4.944

Review 3.  Stromal cells in tissue homeostasis: balancing regeneration and fibrosis.

Authors:  Ton J Rabelink; Melissa H Little
Journal:  Nat Rev Nephrol       Date:  2013-08-13       Impact factor: 28.314

Review 4.  Effector mechanisms of rejection.

Authors:  Aurélie Moreau; Emilie Varey; Ignacio Anegon; Maria-Cristina Cuturi
Journal:  Cold Spring Harb Perspect Med       Date:  2013-11-01       Impact factor: 6.915

5.  CXCR6 plays a critical role in angiotensin II-induced renal injury and fibrosis.

Authors:  Yunfeng Xia; Xiaogao Jin; Jingyin Yan; Mark L Entman; Yanlin Wang
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-05-22       Impact factor: 8.311

Review 6.  Gene targeting to the stroma of the prostate and bone.

Authors:  Roger S Jackson; Omar E Franco; Neil A Bhowmick
Journal:  Differentiation       Date:  2008-05-20       Impact factor: 3.880

Review 7.  Immune system in renal injury and repair: burning the candle from both ends?

Authors:  Michael S Goligorsky
Journal:  Pharmacol Res       Date:  2008-06-08       Impact factor: 7.658

8.  Parabiosis and single-cell RNA sequencing reveal a limited contribution of monocytes to myofibroblasts in kidney fibrosis.

Authors:  Rafael Kramann; Flavia Machado; Haojia Wu; Tetsuro Kusaba; Konrad Hoeft; Rebekka K Schneider; Benjamin D Humphreys
Journal:  JCI Insight       Date:  2018-05-03

Review 9.  Review article: endothelial progenitor cells in renal disease.

Authors:  Michael S Goligorsky; Mei-Chuan Kuo; Daniel Patschan; Marianne C Verhaar
Journal:  Nephrology (Carlton)       Date:  2009-04       Impact factor: 2.506

Review 10.  Macrophage diversity in renal injury and repair.

Authors:  Sharon D Ricardo; Harry van Goor; Allison A Eddy
Journal:  J Clin Invest       Date:  2008-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.